Phase II study of avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC): The TIDE-A study

被引：4

作者：

Iacovelli, R. ^{[1
]}

Ciccarese, C. ^{[1
]}

Bersanelli, M. ^{[2
]}

Zucali, P. A. ^{[3
]}

Fantinel, E. ^{[4
]}

Bimbatti, D. ^{[5
]}

Verzoni, E. ^{[6
]}

Accettura, C. ^{[7
]}

Bonomi, L. ^{[8
]}

Buttigliero, C. ^{[9
]}

Fornarini, G. ^{[10
]}

Pipitone, S. ^{[11
]}

Atzori, F. ^{[12
]}

Masini, C. ^{[13
]}

Massari, F. ^{[14
]}

Primi, F. ^{[15
]}

Buti, S. ^{[16
]}

Perrino, M. R. A. ^{[17
]}

Pafumi, S. ^{[18
]}

Tortora, G. ^{[1
]}

机构：

[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Med Oncol, Rome, Italy

[2] Univ Hosp Parma, Dipartimento Oncol Med, Parma, PR, Italy

[3] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, Italy

[4] AOU Integrata Verona, UOC Oncol Dept, Osped Borgo Trento, Verona, Italy

[5] IOV Ist Oncol Veneto IRCCS, Med Oncol Dept 1, Padua, Italy

[6] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy

[7] Osped Vito Fazzi ASL Lecce, Med Oncol, Lecce, Italy

[8] ASST Papa Giovanni XXIII, Oncol Dept, Bergamo, Italy

[9] Azienda Osped Univ San Luigi Gonzaga, Med Oncol, Orbassano, Italy

[10] IRCCS Osped Policlin San Martino, Hematol & Oncol Dept, Genoa, Italy

[11] Azienda Osped Univ Policlin Modena, Dipartimento Oncol Med, Modena, Italy

[12] Azienda Osped Univ Cagliari, Med Oncol, Monserrato, Italy

[13] Azienda Osped Arcispedale Santa Maria Nuova IRCCS, Oncol Unit, Reggio Emilia, Italy

[14] AOU Policlin S Orsola Malpighi, Oncol Med Padiglione 2, Bologna, Italy

[15] Osped Belcolle ASL Viterbo, Med Oncol, Viterbo, Italy

[16] Univ Parma, Dept Med & Surg, Parma, Italy

[17] IRCCS Humanitas Res Hosp, Dept Oncol, Rozzano, Italy

[18] AOU Integrata Verona Univ Verona, Oncol Dept, Verona, Italy

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1114

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1884MO

引用

页码：S1013 / S1013

页数：1

共 50 条

[1] Updated results of the Tide-A study evaluating avelumab (Ave) plus intermittent axitinib (Axi) in previously untreated patients with metastatic renal cell carcinoma (mRCC).
Arduini, Chiara
Ciccarese, Chiara
Acunzo, Alessandro
Perrino, Matteo
Maruzzo, Marco
Verzoni, Elena
Accettura, Caterina
Bonomi, Lucia
Buttigliero, Consuelo
Cremante, Malvina
Pipitone, Stefania
Scartozzi, Mario
Masini, Cristina
Mollica, Veronica
Primi, Francesca
Strusi, Alessandro
Buti, Sebastiano
Zucali, Paolo Andrea
Fantinel, Emanuela
Iacovelli, Roberto
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : 551 - 551
[2] Phase II study of avelumab plus intermittent axitinib in previously untreated patients with metastatic renal cell carcinoma (Tide-A study)
Iacovelli, Roberto
Atzori, Francesco
Basso, Umberto
Bersanelli, Melissa
Bonomi, Lucia
Bracarda, Sergio
Buttigliero, Consuelo
Fantinel, Emanuela
Calabro, Fabio
Chiuri, Vincenzo Emanuele
Di Lorenzo, Giuseppe
Fornarini, Giuseppe
Massari, Francesco
Naglieri, Emanuele
Ortega, Cinzia
Procopio, Giuseppe
Milella, Michele
Santoni, Matteo
Vitale, Maria Giuseppa
Zucali, Paolo Andrea
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[3] Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study
Iacovelli, Roberto
Ciccarese, Chiara
Buti, Sebastiano
Zucali, Paolo Andrea
Fantinel, Emanuela
Bimbatti, Davide
Verzoni, Elena
Accettura, Caterina
Bonomi, Lucia
Buttigliero, Consuelo
Fornarini, Giuseppe
Pipitone, Stefania
Atzori, Francesco
Masini, Cristina
Massari, Francesco
Primi, Francesca
Strusi, Alessandro
Giudice, Giulia Claire
Perrino, Matteo
Maruzzo, Marco
Milella, Michele
Giannarelli, Diana
Brunelli, Matteo
Procopio, Giuseppe
Tortora, Giampaolo
EUROPEAN UROLOGY, 2024, 86 (05) : 411 - 419
[4] A phase II study of intermittent sunitinib in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC).
Wood, Laura S.
Dreicer, Robert
Garcia, Jorge A.
Gilligan, Timothy D.
Ali, Khaled B.
Haddad, Housam
Shah, Shetal N.
Elson, Paul
Rini, Brian I.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[5] A phase II study of intermittent sunitinib (S) in previously untreated patients (pts) with metastatic renal cell carcinoma (mRCC)
Rini, Brian I.
Wood, Laura S.
Elson, Paul
Zhu, Hui
Chittoria, Namita
Mittal, Kriti
Dreicer, Robert
Gilligan, Timothy D.
Shah, Shetal N.
Garcia, Jorge A.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[6] The role of circulating kidney injury molecule-1 (KIM-1) in metastatic renal cell carcinoma (mRCC): A biomarker analysis of Tide-A, a phase 2 study of first-line avelumab (ave) plus intermittent axitinib (axi).
Ciccarese, Chiara
Agostini, Antonio
Panebianco, Martina
Buti, Sebastiano
Zucali, Paolo Andrea
Bimbatti, Davide
Fantinel, Emanuela
Verzoni, Elena
Accettura, Caterina
Bonomi, Lucia
Buttigliero, Consuelo
Fornarini, Giuseppe
Vitale, Maria Giuseppa
Pedone, Romina Rose
Piro, Geny
Giudice, Giulia Claire
Perrino, Matteo
Tortora, Giampaolo
Carbone, Carmine
Iacovelli, Roberto
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
[7] Phase I/II study of axitinib (axi) and nivolumab (nivo) in patients with metastatic renal cell carcinoma (mRCC).
Zibelman, Matthew R.
Geynisman, Daniel M.
Molina, Ana M.
Malizzia, Lois
Devarajan, Karthik
Luong, Diana
Sullivan, Elizabeth
Carducci, Michael Anthony
Plimack, Elizabeth R.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[8] A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma
Ornstein, Moshe C.
Wood, Laura S.
Elson, Paul
Allman, Kimberly D.
Beach, Jennifer
Martin, Allison
Zanick, Beth R.
Grivas, Petros
Gilligan, Tim
Garcia, Jorge A.
Rini, Brian I.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) : 1764 - +
[9] Re: A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma
Laguna, M. Pilar
JOURNAL OF UROLOGY, 2018, 199 (01): : 23 - 24
[10] Phase II study of lenalidomide in patients (pts.) with metastatic renal cell carcinoma (MRCC).
Choueiri, T. K.
Dreicer, R.
Rini, B. I.
Elson, P.
Garcia, J.
Mekhail, T.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 226S - 226S

← 1 2 3 4 5 →